28
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Formulation Development and Evaluation of Proniosomal Powder of Candesartan

, , &
Pages 567-577 | Received 01 Dec 2016, Accepted 22 Mar 2017, Published online: 30 Oct 2017
 

Abstract

Proniosomal drug delivery system is one of the advancements in nanotechnology. Proniosomes are dry formulations, non ionic surfactant coated carriers. They can be converted into niosomes immediately by hydration. Maltodextrin based proniosomes loaded with Candesartan were prepared by slurry method with different surfactant to cholesterol ratio. The prepared formulations were evaluated for compatibility, flow properties, number of vesicle formation, In vitro release study, solid state characterization (Scanning electron microscopy (SEM), Differential scanning calorimetry (DSC), Powder X-ray diffraction (PXRD)) and stability studies. The niosomal suspensions were further evaluated for entrapment efficiency. The FTIR studies indicated no interaction between Candesartan and excipients. Formulation F8, which showed higher entrapment efficiency of 83.24%, highest number of vesicle formation and in vitro release of 90.1% at the end of 9 h, was found to be best among all the prepared formulations. SEM indicated smooth surface, uniform size and shape of the formed proniosomes. PXRD and DSC studies showed conversion of drug from crystalline to amorphous form. The optimized proniosomal formulation depicted good stability.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.